Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	100.00	18.88	0.00
Graham Fair Price	100.00	2.24	0.00
PEG	100.00	< 0.005	0.00
Price/Book	100.00	1.89	0.00
Price/Cash Flow	100.00	5.37	0.00
Prices/Earnings	-100.00	-2.82	0.00
Price/Sales	100.00	0.74	0.00
Price/FCF	100.00	5.37	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	100.00	0.21	0.00
Operating Margin	-100.00	< 0.005	0.00
ROA	n.A.	-0.05	n.A.
ROE	n.A.	-0.17	n.A.
ROIC	n.A.	-0.01	n.A.
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	-0.02	0.00	-100.00
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	0.00	-1.43	-100.00
EPS QOQ	0.00	-83.61	-100.00
FCF QOQ	0.00	0.52	100.00
Revenue QOQ	0.00	0.08	100.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	12.68	100.00
Days Sales Outstanding (DSO)	0.00	1.10	100.00
Inventory Turnover	n.A.	7.10	n.A.
Debt/Capitalization	0.52	0.56	7.18
Quick Ratio	0.09	0.37	299.58
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	0.00	1.15	100.00
Cash	0.00	0.63	100.00
Capex	0.00	-0.16	-100.00
Free Cash Flow	0.00	0.41	100.00
Revenue	0.00	2.97	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	0.89	0.82	-8.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.00	7.17	100.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating